Ovarian Cancer

As a retired college professor, Dr. McElhiney uses her personal experience with ovarian cancer to advocate for other patients, urging faster development of new treatment options.

In her Introduction to the special edition of CONQUER titled Understanding Biomarkers & Molecular Testing, Lillie D. Shockney, RN, BS, MAS, ONN-CG, briefly explains what biomarkers are, why they are important, and what you should know about them.  

Here are the drugs and financial support services available to patients receiving treatment for ovarian cancer.

Dr. Julian Schink, GYN Oncology Chief of Cancer Treatment Centers of America, provides screening tips and recommendations for these 2 most common gynecologic cancers.

Here are the financial support services available to patients receiving treatment for Ovarian Cancer.

In August 2017, the FDA approved Lynparza tablets for the maintenance treatment of adults with recurrent epithelial ovarian, fallopian tube, or peritoneal cancer who had a response to platinum-based chemotherapy.

Ovarian cancer ranks fifth in cancer-related deaths in women, accounting for more deaths than any other cancer of the female reproductive system.

In 1997 I was 27, happy, free, and traveling the world as a flight attendant. Newly married and ready to have a baby, I felt strong and invincible. My future was unfolding just as I expected it to. Until the symptoms appeared ever so subtly.